EMA seeks public opinion on AI in drug development
Public consultation is open for the European Medicines Agency (EMA)’s…
Public consultation is open for the European Medicines Agency (EMA)’s draft reflection paper on using artificial intelligence (AI) when developing and regulating medicines.